KYNB (KYNB) Stock Price & Analysis
KYNB (KYNB) rose 0.71% to USD 8.55 as of September 8, 2026 at 06:23 UTC, according to Nexqual real-time market data.
KYNB last closed at USD 8.55; the session ranged USD 8.34–8.67 on volume of 11,906 shares. Market capitalization is —, with a 52-week range of USD 6.32–12.58 (NMS). Source: Nexqual, September 8, 2026 at 06:23 UTC.
Key Statistics (as of September 8, 2026 at 06:23 UTC)
| Price | USD 8.55 |
|---|---|
| Change | ▲ 0.71% (up) |
| Previous Close | USD 8.55 |
| Open | USD 8.55 |
| Day Range | USD 8.34 – 8.67 |
| 52-Week Range | USD 6.32 – 12.58 |
| Volume | 11,906 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (KYNB)
Nexqual's technical model rates KYNB "BUY" based on 5 bullish and 2 bearish signals across 128 daily candles, as of September 8, 2026 at 06:23 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 71.13 (overbought) |
| vs SMA50 | Above (USD 7.37) |
| MACD | 0.35 (positive) |
From KYNB's Latest SEC 10-K Filing (filed 2026-03-16)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ATRA | Atara Biotherapeutics, Inc. | USD 9.76 | ▲ 3.39% |
| MGNX | MacroGenics, Inc. | USD 4.4 | ▲ 1.85% |
| KPTI | Karyopharm Therapeutics Inc. | USD 1.79 | ▲ 0% |
| AKBA | Akebia Therapeutics, Inc. | USD 0.97 | ▼ 0.54% |
| ENTA | Enanta Pharmaceuticals, Inc. | USD 14.08 | ▼ 0.07% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 06:23 UTC. This page is informational and not investment advice.